Healthcare >> CEO Interviews >> October 1, 2001
JOSEPH S. PODOLSKI joined Zonagen, Inc. in 1989 as Vice President of
Operations and has served as President and Chief Executive Officer and
as a Director since 1992. Prior to joining Zonagen, Inc., Mr. Podolski
spent 12 years in various engineering, product development and
manufacturing positions at G.D. Searle, a subsidiary of Monsanto
Company. Before joining Monsanto, Mr. Podolski held positions in
manufacturing, engineering, quality control and development of fine
chemicals, antibiotics, pharmaceuticals and hospital products with
Abbott Laboratories, Dearborn Chemical Company and Baxter
Pharmaceuticals. He has been employed in the pharmaceutical industry
since 1970. Mr. Podolski holds an MS in Chemical Engineering from the
Illinois Institute of Technology. He is a named author on 11 issued US
patents covering diverse technologies and has numerous pending patent
applications and concepts of inventions. Profile
TWST: Could you give us a brief overview and summary of Zonagen today?Mr. Podolski: Zonagen was founded in 1987 as a spinoff out of Baylor
College of Medicine. The original intent, oddly